SEC Form 4 · accession 0001437749-19-003403
LEMAITRE VASCULAR INC · LMAT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Trent G Kamke
Officer — Senior V. P., Operations
Period of report
Feb 22, 2019
Accepted (ET)
Feb 26, 2019 · 4:18 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001158895
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 22, 2019 | S | 16,604 | $29.6321 | D | 19,857 | D | |
| Common StockF2 | Feb 26, 2019 | M | 11,146 | $7.87 | A | 31,003 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $7.87 | Feb 26, 2019 | M | 11,146 | D | Jul 24, 2014 | Jul 24, 2021 | Common Stock | 11,146 | 3,145 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $29.46 to $29.80. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
- F2Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
- F3This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, and the balance vesting in equal annual installments over the remaining four years.